RT BSCN (@BSCNews)🔶 2025 REVIEW - $CORE: When it comes to projects leading in the $BTC development space, @Coredao_Org might just be the leader... https://t.co/Rz3KnxEk1C ...

Voltalia wins two new construction contracts in Ireland Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energies, has been chosen by ESB, a semi-state-owned utility company, to provide engineering, procurement and construction (EPC) services for two new solar power plants ESB has reaffirmed its trust in Voltalia by awarding two new turnkey Engineering, Procurement and Construction (EPC) contracts for solar power plants, totaling 92.9 megawatts. The contracts cover t ...

Core Insights - Roche Holding AG reported sales of CHF 30.9 billion for the first half of 2025, reflecting a 4% year-over-year increase, with a 7% rise at constant exchange rates [1][8] - Core earnings per share reached CHF 11.08, up 12% year-over-year at constant exchange rates [1][8] - The company operates under two divisions: Pharmaceuticals and Diagnostics, with all growth rates mentioned being year-over-year and at constant exchange rates [1] Pharmaceuticals Division - Sales in the Pharmaceuticals Division grew 10% to CHF 24 billion, driven by strong demand for key drugs such as Phesgo, Xolair, Hemlibra, Vabysmo, and Ocrevus [2][8] - The top five growth drivers generated total sales of CHF 10.6 billion, an increase of CHF 1.7 billion at constant exchange rates compared to the first half of 2024 [5][8] - Notable drug performances include Ocrevus with sales of CHF 3.5 billion (up 8%), Hemlibra with CHF 2.4 billion (up 17%), and Vabysmo with CHF 2.1 billion (up 18%) [6][10] Diagnostics Division - The Diagnostics Division's sales remained flat at CHF 7 billion, with strong demand for pathology solutions and blood screening tests offsetting the impact of healthcare pricing reforms in China [2] Market Performance - Roche's shares have increased by 20.4% year-to-date, significantly outperforming the industry growth of 0.9% [3] Financial Performance - Second-quarter 2025 revenues were CHF 15.5 billion, an 8% increase at constant exchange rates, primarily driven by the Pharmaceuticals Division [4] - Core operating profit grew 11%, supported by higher sales and effective cost management [12] Future Outlook - Roche expects total sales to grow in the mid-single-digit range at constant exchange rates for 2025, with core earnings per share anticipated to grow in the high single-digit range [13] - The company plans to increase its dividend in Swiss francs further [13] Pipeline Updates - The European Commission approved Itovebi for advanced breast cancer treatment, while the FDA issued a complete response letter for Columvi [14][15] - Roche is advancing prasinezumab into phase III development for early-stage Parkinson's disease [16] Challenges - The company faces potential sales declines due to loss of exclusivity for key drugs and disappointing performance in the Diagnostics Division [20]

Clermont-Ferrand – July 24, 2025 – 5:45 pm COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN In an erratic environment affecting the Group’s markets and trading currencies, Michelin delivered first-half segment operating income of €1.5 billion backed by a powerful price-mix effect. The Group maintains its ambitions for 2025. The Group's first-half results reflect lower Original Equipment volumes but a powerful price-mix effect. At €13.0 billion, sales were down 3.4% for the period, including a 1.5% negative c ...

[Music] It's a pleasure to be with you today. My name is Michael Alba and I'm a principal applied scientist at Microsoft and today I'm going to be presenting on building applications with AI agents. So just as a brief bio, I've been at Microsoft for about two years.So why I've been one of the key contributors to security copilot and the recently announced security copilot agents specifically working in the cyber security division. Before that I spent four years working on machine learning at Uber lots of bi ...

How CMOs Can Help The UN Meet Its Sustainable Development Goals https://t.co/Ma017wwRSl https://t.co/EZuyB2E3j1 ...

Discover FlowMaker, LlamaIndex's new experimental open source visual agent builder that lets you create AI agents using drag-and-drop without writing code. In this demo, Laurie Voss walks you through building agents that can use tools. Try it out yourself! https://flowmaker.llamaindex.ai/ Clone and remix it: https://github.com/run-llama/flow-maker ## What You'll See: **Basic Agent Creation:** Build your first conversational agent by connecting user input nodes to language models, then watch FlowMaker automa ...

RT BSCN (@BSCNews)🔶 2025 REVIEW - $CORE: When it comes to projects leading in the $BTC development space, @Coredao_Org might just be the leader... https://t.co/Rz3KnxEk1C ...

VANCOUVER, CANADA, July 24, 2025 (GLOBE NEWSWIRE) -- QUEST WATER GLOBAL, INC. (OTCID: QWTR) ("Quest" and/or the "Company"), announced today that the Company has entered into a strategic partnership agreement in the Democratic Republic of Congo (“DRC”) with the National Office for Rural Hydraulics (“ONHR”), a branch of the Ministry of Rural Development (“MRD”). The agreement creates a 10-year public-private partnership between the Company and ONHR. The project governed by the agreement aims to provide afford ...

Core Perspective - Crocs, Inc. has launched a community impact platform called STEP UP TO GREATNESS aimed at positively impacting over 3 million youth globally by equipping them with essential skills and opportunities [1][2] Group 1: STEP UP TO GREATNESS Initiative - The STEP UP TO GREATNESS platform focuses on helping young people gain skills, build confidence, and access opportunities to reach their potential [1][2] - Crocs, Inc. has committed to a multi-year partnership with UNICEF's UPSHIFT program, which aims to equip youth with 21st-century skills through innovation and entrepreneurship [1][3] Group 2: Partnership with UNICEF - UNICEF's UPSHIFT program has graduated 5.2 million participants over the last decade, collectively completing 145 million learning hours across 56 countries [4] - The partnership with Crocs, Inc. is expected to scale the impact of UPSHIFT, focusing on unlocking youth potential and fostering problem-solving skills [4] Group 3: Company Mission and Values - Crocs, Inc. aims to create a more comfortable world for all, which includes supporting communities through initiatives like STEP UP TO GREATNESS [4] - The company emphasizes the importance of creativity, communication, innovation, collaboration, and adaptability as fundamental skills for the future [3]